Author

Philip G. Hewitt

Merck KGaA, Darmstadt (Germany)ORCID 0000-0002-2741-3409Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Dorota KurekiD· 1 shared Isabel Koscielski· 1 shared Kinga KosimiD· 1 shared Stefanie HoffmanniD· 1 shared Wouter Strijker· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Dorota KurekORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyFrontiers in Drug DiscoveryPeer-reviewedJan 3, 2025

Validation of an MPS based intestinal cell culture model for the evaluation of drug-induced toxicity

Stefanie Hoffmann, Philip G. Hewitt, Isabel Koscielski…·Kinga Kosim

This paper validates an MPS intestinal cell culture model for assessing drug-induced toxicity by comparing TEER measurements to 2D models and testing 23 compounds.

4 citations

humanbulk RNA-seq

𝕏 PostBluesky